Research location
Akita
Akita, Japan
Advertisement
Research activity in Akita
Akita, JapanCureCurrent currently publishes aggregate city-level research activity for this location: 17 trials and 21 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Akita
17 linked trials · page 1 of 1Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With SchizophreniaNCT05368558 · 2022-08-18 · 1 site observation
TERMINATED
A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in JapanNCT05359081 · 2022-05-16 · 1 site observation
TERMINATED
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117 · 2020-10-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ TabletsNCT04340115 · 2020-04-24 · 4 site observations
COMPLETED
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate CancerNCT04100018 · 2020-02-06 · 1 site observation
COMPLETED
Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's DiseaseNCT02906488 · 2016-09-12 · 1 site observation
COMPLETED
The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)NCT02137733 · 2013-06-01 · 1 site observation
UNKNOWN
Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)NCT01614886 · 2012-07-01 · 1 site observation
COMPLETED
Double-blind Comparative Study of SYR-472NCT01632007 · 2012-05-01 · 1 site observation
COMPLETED
Long-term Study of SYR-472NCT01431807 · 2011-09-01 · 1 site observation
COMPLETED
A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type DementiaNCT01276353 · 2011-01-01 · 1 site observation
COMPLETED
Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01285492 · 2011-01-01 · 1 site observation
COMPLETED
Symbicort Turbuhaler 30/60 Clinical Experience InvestigationNCT01232348 · 2010-01-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT01069289 · 2010-01-01 · 1 site observation
COMPLETED
Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT01047553 · 2009-12-01 · 1 site observation
COMPLETED
Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mgNCT00919477 · 2009-05-01 · 1 site observation
COMPLETED
A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020NCT00165659 · 2002-11-01 · 2 site observations
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.